# Dabigatran Etexilate

NDC: 0904-7253
Generic name: Dabigatran Etexilate
Labeler / Manufacturer: Major Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, COATED PELLETS
Routes: ORAL
Marketing started: 20250623

FDA application: ANDA208040

## Active ingredients

- DABIGATRAN ETEXILATE MESYLATE: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0904-7253"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0904-7253
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b76b79ce-b7dd-4390-b40e-71ae6c477d10